Highbridge Capital Management LLC Aclaris Therapeutics, Inc. Transaction History

Highbridge Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $4.94 Million - $6.1 Million	-300,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $1.71 Million - $2.56 Million	100,000 Added 50.0%	300,000 $5.26 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $2.15 Million - $2.78 Million	100,000 Added 100.0%	200,000 $4.93 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $2.3 Million - $2.88 Million	100,000	100,000 $2.58 Million

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.